SCHEMBL802572

SCHEMBL802572

CC(=O)Nc1nc(=O)n([C@@H]2O[C@]34CO[Si](C(C)C)(C(C)C)O[Si](C(C)C)(C(C)C)O[C@@H]3C2ON(C)C4)cc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL802642 0.85 — —
SCHEMBL802588 0.81 ADORA3 (0.35) —
SCHEMBL802599 0.80 — —
SCHEMBL802625 0.79 TK1 (0.34) —
SCHEMBL25968862 0.79 TK1 (0.34) —
SCHEMBL802664 0.78 TAS1R3 (0.42) —
SCHEMBL14066106 0.78 ABL1 (0.31) —
SCHEMBL14066105 0.77 ABL1 (0.33) —
SCHEMBL802564 0.71 PRMT6 (0.38) —
SCHEMBL15478067 0.71 ACHE (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8653254-B2 Process for producing nucleoside TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-02-18 — — US disclosed
US-20120071646-A1 PROCESS FOR PRODUCING NUCLEOSIDE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-22 — — US disclosed
Send feedback